Spring 2024 Vizient PSO In-Person Meeting: Leveraging PSO Collaboration to Create Resilient Learning Organizations - Day 1

Chicago, IL US
May 9, 2024

The meeting will consist of presentations and panel discussions by leaders and subject matter experts in healthcare quality and patient safety. Attendees will hear about strategies for improving healthcare quality, patient safety, and outcomes using a combination of didactic learning, interactive discussions, case reviews, and Q&A.

Target Audience

  • Nurses
  • Pharmacists
  • Physicians
  • Other Healthcare Professionals

Learning Objectives

At the conclusion of this activity, participants should be able to:  

  • Identify leadership behaviors and tactics for advancing high-reliability and safety culture.
  • Discuss interventions for improving patient safety, healthcare quality, and outcomes.
  • Describe strategies that promote continuous learning and improvement.

 

 

Pharmacists

At the conclusion of this activity, pharmacists should be able to:

  • Identify leadership behaviors and tactics for advancing high-reliability and safety culture.
  • Discuss interventions for improving patient safety, healthcare quality, and outcomes.
  • Describe strategies that promote continuous learning and improvement.
Course summary
Available credit: 
  • 5.75 ACPE Pharmacist
  • 5.75 AMA PRA Category 1 Credit™
  • 5.75 ANCC
  • 5.75 General CE - Attendance
Course opens: 
05/09/2024
Course expires: 
07/08/2024
Event starts: 
05/09/2024 - 9:00am CDT
Event ends: 
05/09/2024 - 4:30pm CDT
Vizient - The Old Post Office
433 W Van Buren St
Chicago, IL 60607
United States

FACULTY & PLANNERS

Faculty

Nikita Arora, MPH
Senior Consultant, Intelligence
Sg2

Jonathan Burdick, MD
Chief Medical Officer
Uptown Community Health Center

Craig Clapper, PE
Executive Advisor
SSM Health

Jane Domingo, MBA, MS, CCC-SLP
Program Manager, NMIS
Northwestern Medicine

 

Dana Edelson, MD, MS
Executive Director of Rescue and Resilience
University of Chicago

Tami Flemmer, MSN, RN, CPHRM
Senior Director Risk Management
Sanford Health

Ellen Flynn, RN, MBA, JD
Principal
Vizient, Inc
.

Allan Frankel, MD
Managing Principal
Vizient Safe and Reliable

Tara Ganley, BSN, RN-BC, CPHQ
Performance Improvement Specialist
Carle Foundation Hospital

Manjot Gill, MD
Professor of Ophthalmology & Medical Education
Northwestern Medicine

Katherine Hochman, MD, MBA
Director, Division of Hospital Medicine
NYU Langone Health
Associate Chair, Quality, NYU Department of Medicine
NYU Langone

Jennifer House, MBA, CSSBB
Senior Advisor, Office of the Chief Clinical Chair
Intermountain Health

Serina Johnson, DNP, RN, PHN
Nurse Researcher
Gundersen Health System

Michael Leonard, MD
Executive Principal
Vizient Safe and Reliable

Sumita Markan-Aurora, MD
System Director Patient Safety and Clinical Outcomes
SSM Health

Julie McGuire, MSN, RN, CPHQ, CPPS
Patient Safety Program Manager
Northwestern Medicine

Heather Meyer, MHA
Project Manager
Gundersen Health System

Suzanne Miller, MSN, RN
Sr. Consulting Director
Vizient Safe and Reliable

Siddhartha Singh, MD, MS, MBA
Enterprise Chief Quality and Safety Officer
Froedtert Health & The Medical College of Wisconsin

Kristin Soland, BAN, CPHQ, PCN, RN
Quality Improvement Nurse
Gundersen Health System

Shelly Tran, MSN, RN, CSSBB, CPHQ
Manager, Ambulatory Performance Improvement
Intermountain Health

Tammy Williams, MSN, RN
Program Director
Vizient, Inc.

 

Planning Committee

Ellen Flynn, RN, MBA, JD    (Course Director)
Principal                   
Vizient, Inc.

 
Donald Kennerly, MD      

​​Senior HRO Advisor​                  
Vizient, Inc.

 
Kathryn Merkeley, MHSA, RN     

PI Program Director                   
Vizient, Inc.

 
Tammy Williams, MSN    

PI Program Director                  
Vizient, Inc.

 
James Lichauer, PharmD 

​​Sr PI Program Director, Pharmacy​                   
Vizient, Inc.
 
Marilu Kelly, MSN, RN, NPD-BC, CHCP
Director, Continuing Education       
Vizient, Inc.
 
Kim Bentley, CHCP   
CE Programs Manager              
Vizient, Inc.
 
 

DISCLOSURE

As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
 
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
 
Disclosure Statements

Relevant Financial Relationships

Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.

Manjot Gill, MD, speaker for this educational activity, is a consultant for Genetech-Roche and Regeneron.

Siddhartha Singh, MD, MS, MBA, speaker for this educational activity, is a consultant for Astra Zeneca.

 

All relevant financial relationships listed for these individual(s) have been mitigated.

All others in a position to control content for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
 
Statement of Content Validity
 
Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
 
FDA Off-Label Use
 
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
 

Disclaimer

The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.


 

Joint Accreditation Statement

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Designation Statement(s)

 

Nurses (CNE)

 
This activity is designated for 5.75 contacts hours.
 
Vizient, Inc. is approved by the California Board of Registered Nursing, Provider Number CEP12580, for 5.75 contact hours.
 
Pharmacists (CPE)
 
Vizient, Inc. designates this live activity for a maximum of 5.75 contact hours for Pharmacists.
 
Universal Activity Number:  JA0006103-0000-24-032-L05-P
 
 
Physicians (CME)
 
Vizient, Inc. designates this live activity for a maximum of  5.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
 
Other Healthcare Professionals (General CE Credit)
 
Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation.  Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.

 

 

Available Credit

  • 5.75 ACPE Pharmacist
  • 5.75 AMA PRA Category 1 Credit™
  • 5.75 ANCC
  • 5.75 General CE - Attendance
Please login or register to take this course.

 

Select the “Obtain Credit” button to access the activity evaluation and to claim CE Credit.
 
Please Note: 
  • If the "Register/Take Course" tab is displayed instead of the "Obtain Credit" tab, you must first login to proceed with the credit claim process.
  • This activity requires learners to confirm their attendance using an activity code. An Access Denied error message indicates that your attendance was not recorded via SMS text or QR code scanning.
Please click here to enter the code you received at the end of the activity to verify your attendance if you have not already done so: https://continuingeducation.vizientinc.com/code

 

 

Required Hardware/software

 

The Vizient CE Learner Portal is compatible with most modern web browsers (such as Firefox, Google Chrome, Microsoft Edge, Apple Safari) and can also be accessed with mobile devices.